Related Experiment Video
Updated: Apr 19, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Association between triglyceride-glucose-frailty index and metabolic dysfunction-associated fatty liver disease:
Shixian Ruan1,2, Shuanglong Liu2,3, Xinmei Zhang1
1Department of Gastroscopy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
Abstract:
The triglyceride-glucose frailty index (TyGFI), integrating metabolic dysfunction and physiological decline, has been proposed as a novel marker of cardiometabolic risk. Its association with metabolic dysfunction-associated steatotic liver disease (MASLD), however, remains unclear. Our objective was to assess TyGFI's predictive value for MASLD risk and to explore the mediating role of obesity indices in the relationships among insulin resistance, aging, and MASLD. Using data from 988 participants aged ≥45 years in the 2017-2018 National Health and Nutrition Examination Survey, we examined the relationship between TyGFI and MASLD. MASLD was defined by controlled attenuation parameter (CAP ≥ 278 dB/m) and at least 1 cardiometabolic risk factor. Multivariable logistic regression, restricted cubic spline, subgroup, and receiver operating characteristic analyses were conducted. Mediation analysis was applied to assess the role of obesity indicators, including body mass index, waist circumference, lipid accumulation product, and visceral adiposity index. Elevated TyGFI was independently associated with an increased prevalence of MASLD, with a significant dose-response relationship across quartiles. The association was consistent across demographic and clinical subgroups. receiver operating characteristic analysis indicated modest predictive ability (AUC = 0.62). All 4 obesity indicators correlated strongly with TyGFI and MASLD; mediation analyses showed that body mass index, waist circumference, and lipid accumulation product significantly mediated the TyGFI-MASLD association, whereas visceral adiposity index did not. TyGFI is independently associated with MASLD risk in middle-aged and older adults, with much of its effect mediated through obesity-related pathways. These findings highlight the potential of TyGFI as a risk assessment tool and underscore the importance of obesity control in MASLD prevention.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

